Equillium (EQ) Enterprise Value (2017 - 2026)
Equillium's (EQ) quarterly Enterprise Value came in at -$61.3 million in Q1 2026, down 322.91% year-on-year from $27.5 million in Q1 2025, and down 106.24% on a QoQ basis from -$29.7 million in Q4 2025.
Equillium (EQ) Enterprise Value (2017 - 2026) Analysis & Trends
Equillium (EQ) has 10 years of Enterprise Value data on file, last reported at -$61.3 million in Q1 2026.
- On a quarterly basis, Enterprise Value fell 322.91% year-over-year to -$61.3 million in Q1 2026; TTM through Mar 2026 was -$61.3 million, a 322.91% decrease from a year earlier, with the FY2025 full-year figure at -$29.7 million, down 31.71% from the prior year.
- Enterprise Value for Q1 2026 stood at -$61.3 million, down from -$29.7 million in the prior quarter.
- Over the last five years, Enterprise Value for EQ reached as high as -$10.3 million in Q2 2025 and fell as low as -$71.0 million in Q4 2022.
- Historically, Enterprise Value has averaged -$41.3 million across 5 years, with a median of -$40.9 million in 2023.
- Across the five-year window, Enterprise Value soared 69.17% in 2025 and sank 322.91% in 2026, its largest moves.
- Year by year, Enterprise Value stood at -$71.0 million in 2022, then surged by 42.46% to -$40.9 million in 2023, then jumped by 44.76% to -$22.6 million in 2024, then plunged by 31.71% to -$29.7 million in 2025, then sank by 106.24% to -$61.3 million in 2026.
- Per Business Quant data, the three most recent Enterprise Value figures were -$61.3 million in Q1 2026, -$29.7 million in Q4 2025, and -$33.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -283.54 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | -61.40 Mn |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -2.83 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | -4.79 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | -7.25 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -8.75 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -1.91 Bn |
| 10 | Equillium | 242.14 Mn | 242.14 Mn | - | -61.32 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -61.32 Mn |
| Dec 31, 2025 | -29.73 Mn |
| Sep 30, 2025 | -33.10 Mn |
| Jun 30, 2025 | -10.27 Mn |
| Mar 31, 2025 | -14.50 Mn |
| Dec 31, 2024 | -22.58 Mn |
| Sep 30, 2024 | -25.88 Mn |
| Jun 30, 2024 | -33.30 Mn |
| Mar 31, 2024 | -32.29 Mn |
| Dec 31, 2023 | -40.87 Mn |
| Sep 30, 2023 | -46.31 Mn |
| Jun 30, 2023 | -48.38 Mn |
| Mar 31, 2023 | -61.99 Mn |
| Dec 31, 2022 | -71.02 Mn |
| Sep 30, 2022 | -44.52 Mn |
| Jun 30, 2022 | -57.56 Mn |
| Mar 31, 2022 | -68.82 Mn |
| Dec 31, 2021 | -80.71 Mn |
| Sep 30, 2021 | -90.69 Mn |
| Jun 30, 2021 | -97.64 Mn |